Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating the effectiveness and safety of OZURDEX in patients with diabetic macular edema who have not been treated before.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED